Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Medtronic
Baxter
Harvard Business School
Moodys
Johnson and Johnson

Last Updated: June 29, 2022

Details for Patent: 8,146,588


✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 8,146,588
Title:Unit dose capsules and dry powder inhaler
Abstract: Described are dry powder inhalers composing an intake section, a mixing section and a mouthpiece. The mixing section can accommodate a capsule having a top keying portion and containing a dry powder medicament. The top keying portion of the capsules may fit within complementary keying structures in inhaler mixing sections.
Inventor(s): Steiner; Solomon S. (Mount Kisco, NY), Feldstein; Robert (Yonkers, NY), Fog; Per B. (Bedford Hills, NY), Poole; Trent A. (South Amherst, MA)
Assignee: MannKind Corporation (Valencia, CA)
Application Number:11/949,707
Patent Claim Types:
see list of patent claims
Dosage form; Delivery; Device;

Drugs Protected by US Patent 8,146,588

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 8,146,588

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 339981 See Plans and Pricing
Austria 390944 See Plans and Pricing
Australia 2004270204 See Plans and Pricing
Australia 2005201843 See Plans and Pricing
Australia 2009201564 See Plans and Pricing
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Medtronic
Express Scripts
Baxter
Merck
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.